P. Soloff

发表

Impulsivity and prefrontal hypometabolism in borderline personality disorder

Carolyn Cidis Meltzer, Phil J. Greer, C. Meltzer, 2003, Psychiatry Research: Neuroimaging.

A fenfluramine-activated FDG-PET study of borderline personality disorder

Carolyn C Meltzer, C. Meltzer, Phil J. Greer, 2000, Biological Psychiatry.

Stress and hippocampal abnormalities in psychiatric disorders

P. Brambilla, P. Brambilla, J. C. Soares, 2004, European Neuropsychopharmacology.

Recent life events, social adjustment, and suicide attempts in patients with major depression and borderline personality disorder.

K. Lynch, J. Mann, G. Haas, 2000, Journal of personality disorders.

Affective interference in borderline personality disorder: The lethality of suicidal behavior predicts functional brain profiles.

V. Diwadkar, Asadur Chowdury, P. Soloff, 2019, Journal of affective disorders.

Effects of serotonin-2A receptor binding and gender on personality traits and suicidal behavior in borderline personality disorder

J. Price, N. Mason, L. Chiappetta, 2014, Psychiatry Research: Neuroimaging.

Hyper-modulation of brain networks by the amygdala among women with Borderline Personality Disorder: Network signatures of affective interference during cognitive processing.

V. Diwadkar, Ashley Burgess, Karthik Ramaseshan, 2017, Journal of psychiatric research.

5HT2A Receptor Binding is Increased in Borderline Personality Disorder

J. Price, C. Meltzer, A. Fabio, 2007, Biological Psychiatry.

The amphetamine challenge test in patients with borderline disorder.

S. Schulz, J. Cornelius, P. Soloff, 1988, The American journal of psychiatry.

Borderline personality disorder: stress reactivity or stress generation? A prospective dimensional study

M. Hallquist, T. Allen, A. Dombrovski, 2020, Psychological Medicine.

Efficacy and tolerability of olanzapine in the treatment of schizotypal personality disorder

M. Keshavan, M. Shad, N. Schooler, 2004, Schizophrenia Research.

Amitriptyline versus haloperidol in borderlines: final outcomes and predictors of response.

J. Cornelius, P. Soloff, J. Perel, 1989, Journal of clinical psychopharmacology.

Subtyping borderline personality disorder by suicidal behavior.

L. Chiappetta, P. Soloff, 2012, Journal of personality disorders.

Medically and Surgically Treated Coronary Patients in Cardiovascular Rehabilitation: A Comparative Study

P. Soloff, 1979, International journal of psychiatry in medicine.

Childhood abuse as a risk factor for suicidal behavior in borderline personality disorder.

K. Lynch, T. Kelly, P. Soloff, 2002, Journal of personality disorders.

Psychiatric disorders in the families of borderline patients.

P. Soloff, J. Millward, 1983, Archives of general psychiatry.

Affect, impulse and psychosis in borderline disorders: a validation study.

P. Soloff, 1981, Comprehensive psychiatry.

Developmental histories of borderline patients.

P. Soloff, J. Millward, 1983, Comprehensive psychiatry.

The dexamethasone suppression test in patients with borderline personality disorders.

P. Soloff, R. Nathan, A. George, 1982, The American journal of psychiatry.

Effects of denial on mood, compliance, and quality of functioning after cardiovascular rehabilitation.

P. Soloff, 1980, General hospital psychiatry.

EEG sleep evaluation of depression in borderline patients.

D. Kupfer, C. Reynolds, D. Spiker, 1984, The American journal of psychiatry.

La terapia farmacologica nel disturbo di personalità borderline

P. Soloff, 2010 .

Denial and Rehabilitation of the Post-Infarction Patient

P. Soloff, 1978, International journal of psychiatry in medicine.

Mediators of the relationship between childhood sexual abuse and suicidal behavior in borderline personality disorder.

A. Fabio, U. Feske, P. Soloff, 2008, Journal of personality disorders.

Can we study (treat) borderline patients? Attrition from research and open treatment.

R. Ulrich, T. Kelly, J. Cornelius, 1992 .

Self-mutilation and suicidal behavior in borderline personality disorder

R. Ulrich, T. Kelly, J. Cornelius, 1994 .

Schizotypal symptoms in patients with borderline personality disorders.

P. Soloff, A. George, 1986, The American journal of psychiatry.

A comparison of borderline with depressed and schizophrenic patients on a new diagnostic interview.

P. Soloff, 1981, Comprehensive psychiatry.

Concurrent validation of a diagnostic interview for borderline patients.

P. Soloff, 1981, The American journal of psychiatry.

The Liaison Psychiatrist in Cardiovascular Rehabilitation: An Overview

P. Soloff, 1978, International journal of psychiatry in medicine.

Paradoxical effects of amitriptyline on borderline patients.

P. Soloff, J. Perel, R. Nathan, 1986, The American journal of psychiatry.

Seclusion and restraint in 1985: a review and update.

T. Gutheil, D. Wexler, P. Soloff, 1985, Hospital & community psychiatry.

Patterns of Seclusion: A Prospective Study

P. Soloff, S. M. Turner, 1981, The Journal of nervous and mental disease.

The pharmacological treatment of delusional depression.

R. Dealy, D. Spiker, P. Soloff, 1985, The American journal of psychiatry.

Civil commitment and the rights of the unborn.

L. Roth, P. Soloff, S. Jewell, 1979, The American journal of psychiatry.

Progress in pharmacotherapy of borderline disorders. A double-blind study of amitriptyline, haloperidol, and placebo.

R. Ulrich, P. Soloff, J. Perel, 1986, Archives of general psychiatry.

Clinical outcome of ECT in patients with major depression and comorbid borderline personality disorder.

H. Sackeim, B. Mulsant, P. Pilkonis, 2004, The American journal of psychiatry.

Characteristics of suicide attempts of patients with major depressive episode and borderline personality disorder: a comparative study.

K. Lynch, J. Mann, K. Malone, 2000, The American journal of psychiatry.

Risk factors for suicidal behavior in borderline personality disorder.

R. Ulrich, J. Cornelius, P. Soloff, 1994, The American journal of psychiatry.

EEG abnormalities in borderline personality disorder: Specific or nonspecific

S. Schulz, R. Brenner, J. Cornelius, 1986, Biological Psychiatry.

Psychopharmacology of borderline personality disorder.

P. Soloff, 2000, The Psychiatric clinics of North America.

Psychotic denial of third-trimester pregnancy.

P. Soloff, R. I. Slayton, 1981, The Journal of clinical psychiatry.

Suicidal Behavior and Psychosocial Outcome in Borderline Personality Disorder at 8-Year Follow-Up.

L. Chiappetta, P. Soloff, 2017, Journal of personality disorders.

Paranoia, homicidal behavior, and seizures associated with phenylpropanolamine.

C. Reynolds, J. Cornelius, P. Soloff, 1984, The American journal of psychiatry.

Hippocampal volume in adolescent-onset alcohol use disorders.

M. Keshavan, M. D. De Bellis, S. Beers, 2000, The American journal of psychiatry.

Anatomical MRI study of borderline personality disorder patients

Paolo Brambilla, Matcheri S Keshavan, M. Keshavan, 2004, Psychiatry Research: Neuroimaging.

Structural brain abnormalities in borderline personality disorder: A voxel-based morphometry study

Vaibhav Diwadkar, Dhruman Goradia, V. Diwadkar, 2008, Psychiatry Research: Neuroimaging.

The depressed borderline: one disorder or two?

J. Cornelius, P. Soloff, A. George, 1991, Psychopharmacology bulletin.

Diagnostic interview for borderline patients. A replication study.

R. Ulrich, P. Soloff, 1981, Archives of general psychiatry.

10-Year Outcome of Suicidal Behavior in Borderline Personality Disorder.

L. Chiappetta, P. Soloff, 2019, Journal of personality disorders.

Is there any drug treatment of choice for the borderline patient?

P. Soloff, 1994, Acta psychiatrica Scandinavica. Supplementum.

Efficacy of phenelzine and haloperidol in borderline personality disorder.

R. Ulrich, J. Cornelius, P. Soloff, 1993, Archives of general psychiatry.

A preliminary trial of fluoxetine in refractory borderline patients.

R. Ulrich, J. Cornelius, P. Soloff, 1991, Journal of clinical psychopharmacology.

Continuation pharmacotherapy of borderline personality disorder with haloperidol and phenelzine.

R. Ulrich, J. Cornelius, P. Soloff, 1993, The American journal of psychiatry.

Pharmacotherapy of borderline disorders.

P. Soloff, 1981, Comprehensive psychiatry.

Prospective predictors of suicidal behavior in borderline personality disorder at 6-year follow-up.

L. Chiappetta, P. Soloff, 2012, The American journal of psychiatry.

Structural brain abnormalities and suicidal behavior in borderline personality disorder.

V. Diwadkar, P. Pruitt, J. Radwan, 2012, Journal of psychiatric research.

High-lethality status in patients with borderline personality disorder.

J. Mann, A. Fabio, K. Malone, 2005, Journal of personality disorders.

What's New in Personality Disorders?: An Update on Pharmacologic Treatment

P. Soloff, 1990 .

Behavioral precipitants of restraint in the modern milieu.

P. Soloff, 1978, Comprehensive psychiatry.

Borderline Syndrome-Reply

P. Soloff, 1982 .

Competency to decide about treatment or research: an overview of some empirical data.

F. G. Foster, L. Roth, D. Spiker, 1982, International journal of law and psychiatry.

Depression in borderline patients: A prospective EEG sleep study

D. Kupfer, C. Reynolds, L. Taska, 1985, Psychiatry Research.

Pseudohomosexual psychosis in basic military training

P. Soloff, 1978, Archives of sexual behavior.

Impulsivity, aggression and brain structure in high and low lethality suicide attempters with borderline personality disorder

V. Diwadkar, Richard White, P. Soloff, 2014, Psychiatry Research: Neuroimaging.

Prefrontal cortex, thalamus, and cerebellar volumes in adolescents and young adults with adolescent-onset alcohol use disorders and comorbid mental disorders.

Matcheri S Keshavan, M. Keshavan, M. D. De Bellis, 2005, Alcoholism, clinical and experimental research.

Gender differences in a fenfluramine-activated FDG PET study of borderline personality disorder

C. Meltzer, Phil J. Greer, P. Soloff, 2005, Psychiatry Research: Neuroimaging.

Impulsivity, gender, and response to fenfluramine challenge in borderline personality disorder

J. John Mann, J. Mann, K. Malone, 2003, Psychiatry Research.

Serotonin, impulsivity, and alcohol use disorders in the older adolescent: a psychobiological study.

K. Lynch, P. Soloff, H. Moss, 2000, Alcoholism, clinical and experimental research.

Bridging the Gap Between Remission and Recovery in BPD: Qualitative Versus Quantitative Perspectives.

P. Soloff, 2019, Journal of personality disorders.

Time, Age, and Predictors of Psychosocial Outcome in Borderline Personality Disorder.

L. Chiappetta, P. Soloff, 2020, Journal of personality disorders.

Impulsivity and aggression mediate regional brain responses in Borderline Personality Disorder: An fMRI study

V. Diwadkar, Asadur Chowdury, Ashley Burgess, 2017, Psychiatry Research: Neuroimaging.

Gender, personality, and serotonin-2A receptor binding in healthy subjects

Carolyn C. Meltzer, Julie C. Price, J. Price, 2010, Psychiatry Research: Neuroimaging.

Stimulus valence, episodic memory, and the priming of brain activation profiles in borderline personality disorder

V. Diwadkar, Asadur Chowdury, P. Soloff, 2021, Psychological Medicine.

Affective context interferes with brain responses during cognitive processing in borderline personality disorder: fMRI evidence

V. Diwadkar, Karthik Ramaseshan, Richard White, 2015, Psychiatry Research: Neuroimaging.

Changes in EEG mean frequency associated with anxiety and with amphetamine challenge in BPD

S. Schulz, R. Brenner, R. Ulrich, 1988, Biological Psychiatry.

Neuroleptic treatment in the borderline patient: advantages and techniques.

P. Soloff, 1987, The Journal of clinical psychiatry.

Affective Dysregulation in Borderline Personality Disorder May Require Multiple Treatment Methods

P. Soloff, 2003 .

Fluoxetine trial in borderline personality disorder.

R. Ulrich, J. Cornelius, P. Soloff, 1990, Psychopharmacology bulletin.

MRI study of corpus callosum in patients with borderline personality disorder A pilot study

M. Keshavan, J. Soares, P. Brambilla, 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Algorithms for pharmacological treatment of personality dimensions: symptom-specific treatments for cognitive-perceptual, affective, and impulsive-behavioral dysregulation.

P. Soloff, 1998, Bulletin of the Menninger Clinic.

Platelet MAO in borderline personality disorder

J. Cornelius, P. Soloff, J. Perel, 1991, Biological Psychiatry.

Sexual practices among patients with borderline personality disorder.

G. Zubenko, P. Soloff, P. Schulz, 1987, The American journal of psychiatry.

Prospective predictors of suicide attempts in borderline personality disorder at one, two, and two-to-five year follow-up.

A. Fabio, P. Soloff, Paul H Soloff, 2008, Journal of personality disorders.

Physical restraint and the nonpsychotic patient: clinical and legal perspectives.

P. Soloff, 1979, The Journal of clinical psychiatry.

The Pharmacological Treatment of Delusional Depression: Part II

R. Dealy, D. Spiker, P. Soloff, 1986, Journal of clinical psychopharmacology.

Behavioral manifestations of paraneoplastic encephalopathy

J. Cornelius, P. Soloff, Bruce K. Miewald, 1986, Biological Psychiatry.

An evaluation of the significance of selected neuropsychiatric abnormalities in the etiology of borderline personality disorder

S. Schulz, R. Brenner, R. Tarter, 1989 .

Amitriptyline and haloperidol in unstable and schizotypal borderline disorders.

R. Ulrich, P. Soloff, J. Perel, 1986, Psychopharmacology bulletin.

Characterizing depression in borderline patients.

P. Soloff, R. Nathan, P. Schulz, 1987, The Journal of clinical psychiatry.

Pharmacodynamic probes in personality disorders.

S. Schulz, J. Cornelius, P. Soloff, 1987, Psychopharmacology bulletin.

A Family History Study of Borderline Subtypes

S. Schulz, T. Kelly, P. Soloff, 1989 .

Special feature: psychobiologic perspectives on treatment of personality disorders.

P. Soloff, 1997, Journal of personality disorders.